Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(20%)

Results Posted

100%(3 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_1

40%

Ph not_applicable

20%

Ph phase_4

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

2(40.0%)

Phase 4Post-market surveillance

2(40.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (40.0%)

Phase 42 (40.0%)

N/A1 (20.0%)

Trials by Status

terminated120%

completed360%

active_not_recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingphase_4

The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant

NCT00275639

completedphase_1

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

NCT01124162

Clinical Trials (5)

Showing 5 of 5 trials

NCT07547878Phase 4

Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)

Active Not Recruiting

NCT01124175Phase 1

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Completed

NCT01390181Not Applicable

The Effect of Losartan in Bicuspid Aortic Valve Patients

Terminated

NCT00275639Phase 4

The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant

Completed

NCT01124162Phase 1

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5